Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0CL9S
|
|||
| Former ID |
DAP000698
|
|||
| Drug Name |
Telbivudine
|
|||
| Synonyms |
Epavudine; LLT; LdT; Sebivo; Telbivudin; Tyzeka; Telbivudine [USAN]; LDT600; NB 02B; NV 02B; L-Deoxythymidine; L-Thymidine; L-dT; LDT-600; NV-02B; Tyzeka (TN); Beta-L-Thymidine; Telbivudine (USAN/INN); Tyzake/Sebivo (TN); Tyzeka, Sebivo, Telbivudine; 1-(2-Deoxy-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione; 1-(2-Deoxy-beta-L-erythropentafuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione; 1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione; 2'-Deoxy-L-thymidine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Hepatitis B virus infection [ICD-11: 1E51.0; ICD-10: B18.1] | Approved | [1] | |
| Therapeutic Class |
Antiviral Agents
|
|||
| Company |
Idenix
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H14N2O5
|
|||
| Canonical SMILES |
CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O
|
|||
| InChI |
1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16)/t6-,7+,8+/m1/s1
|
|||
| InChIKey |
IQFYYKKMVGJFEH-CSMHCCOUSA-N
|
|||
| CAS Number |
CAS 3424-98-4
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
649439, 866449, 10253548, 12015420, 15220960, 15220961, 46234569, 46508706, 47208326, 50070122, 50070883, 57348574, 79679357, 81044332, 92721242, 99299522, 104234230, 104253286, 113442015, 113585147, 124757407, 125164211, 126619322, 126645820, 126662079, 134224136, 134337987, 135115725, 135611174, 135692211, 135778824, 137005934, 141758313, 152343276, 160657121, 160964596, 172919923, 174007441, 175267960, 176484712, 179150345, 184598259, 210279169, 210281492, 223454562, 223668197, 226495211, 241047041, 241075091, 249582920
|
|||
| ChEBI ID |
CHEBI:63624
|
|||
| ADReCS Drug ID | BADD_D02145 | |||
| SuperDrug ATC ID |
J05AF11
|
|||
| Drug Resistance Mutation (DRM) | Top | |||
|---|---|---|---|---|
| DRM | DRM Info | |||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Hepatitis B virus Polymerase (HBV P) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Nucleoside and nucleotide analogs in the treatment of chronic hepatitis B. Enferm Infecc Microbiol Clin. 2008 May;26 Suppl 7:32-8. | |||
| REF 2 | Nucleos(t)ide analogues for hepatitis B virus: strategies for long-term success. Best Pract Res Clin Gastroenterol. 2008;22(6):1081-92. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.